Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 23, 2021 at 11:55 pm IST
Share
Manhattan Scientifics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 50,000 compared to USD 50,000 a year ago. Operating loss was USD 161,000 compared to USD 128,000 a year ago. Net loss was USD 2.583 million compared to net income of USD 528,000 a year ago. For the half year, sales was USD 50,000 compared to USD 50,000 a year ago. Operating loss was USD 345,000 compared to USD 300,000 a year ago. Net loss was USD 2.449 million compared to USD 204,000 a year ago.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.